Insulet Corp., DexCom partner for glucose monitoring

January 8, 2008

Insulet, DexCom announce development agreement for glucose monitoring.

Insulet Corp., a manufacturer of wearable insulin pump technology with its OmniPod Insulin Management System, and DexCom Inc., a provider of continuous glucose monitoring systems for people with diabetes, have signed a development agreement to integrate DexCom's continuous glucose monitoring technology into the wireless, handheld OmniPod System Personal Diabetes Manager (PDM). In addition to programming the patient's insulin delivery, the PDM with integrated DexCom technology will receive and display continuous glucose readings from DexCom's wearable sensor transmitter. The companies announced that their integrated system will debut mid-2009.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, click here.